We are live on ! Find out more
MWNA

Marshall Wace North America Portfolio holdings

AUM $23.5B
1-Year Est. Return 46.46%
This Fund
S&P 500
This Quarter Est. Return
+5.07%
1 Year Est. Return
+46.46%
3 Year Est. Return
+108.51%
5 Year Est. Return
10 Year Est. Return
AUM
$15.8B
AUM Growth
+$2.12B
Cap. Flow
+$1.31B
Cap. Flow %
8.29%
Top 10 Hldgs %
13.54%
Holding
1,739
New
469
Increased
384
Reduced
350
Closed
529

Sector Composition

Rank Sector Weight
1 Healthcare 19.65%
2 Technology 16.89%
3 Consumer Discretionary 13.55%
4 Industrials 12.67%
5 Financials 6.71%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CL icon
76
Colgate-Palmolive
CL
$73.7B
$47.9M 0.3%
656,264
+283,037
+76% +$20.4M
TSE
77
DELISTED
Trinseo
TSE
$47.9M 0.3%
714,343
-9,599
-1% -$639K
GPN icon
78
Global Payments
GPN
$24B
$46.8M 0.3%
492,428
+175,239
+55% +$16.5M
CYBR
79
DELISTED
CyberArk
CYBR
$46.3M 0.29%
1,128,555
-305,510
-21% -$12.9M
RIO icon
80
Rio Tinto
RIO
$161B
$46.1M 0.29%
981,655
+758,677
+340% +$35.3M
HWM icon
81
Howmet Aerospace
HWM
$116B
$45.7M 0.29%
2,382,430
+1,075,510
+82% +$20.6M
STAY
82
DELISTED
Extended Stay America, Inc. Paired Share Unit
STAY
$45.3M 0.29%
2,262,968
-1,852,413
-45% -$36M
MDLZ icon
83
Mondelez International
MDLZ
$78.9B
$44.2M 0.28%
1,078,401
+792,837
+278% +$33.7M
RTN
84
DELISTED
Raytheon Company
RTN
$43.7M 0.28%
233,895
-106,828
-31% -$18.8M
NBIX icon
85
Neurocrine Biosciences
NBIX
$16.9B
$43.6M 0.28%
714,468
+152,128
+27% +$8.03M
PX
86
DELISTED
Praxair Inc
PX
$43.3M 0.27%
309,200
+306,182
+10,145% +$40.8M
MON
87
DELISTED
Monsanto Co
MON
$42.5M 0.27%
354,580
+340,337
+2,390% +$40M
NUVA
88
DELISTED
NuVasive, Inc.
NUVA
$41.9M 0.27%
+762,588
New +$50.5M
ATO icon
89
Atmos Energy
ATO
$28.9B
$41.9M 0.27%
499,098
+94,276
+23% +$8.13M
KDP icon
90
Keurig Dr Pepper
KDP
$42.2B
$41.7M 0.26%
473,639
-245,732
-34% -$22.3M
DEO icon
91
Diageo
DEO
$48.9B
$41.5M 0.26%
314,533
+167,965
+115% +$21.7M
EA icon
92
Electronic Arts
EA
$53B
$41.5M 0.26%
351,386
-148,580
-30% -$17.2M
AOS icon
93
A.O. Smith
AOS
$8.57B
$41.3M 0.26%
699,604
+647,337
+1,239% +$36.3M
PRAH
94
DELISTED
PRA Health Sciences, Inc.
PRAH
$41.3M 0.26%
542,890
+162,882
+43% +$12.3M
GRMN
95
Garmin
GRMN
$59.6B
$41.1M 0.26%
761,109
+28,910
+4% +$1.5M
FLS icon
96
Flowserve
FLS
$10.2B
$41.1M 0.26%
955,047
+689,817
+260% +$29M
EW icon
97
Edwards Lifesciences
EW
$51.5B
$40.5M 0.26%
1,114,623
-1,535,901
-58% -$58.6M
GNTX icon
98
Gentex
GNTX
$5.12B
$40.2M 0.25%
2,012,048
+1,788,629
+801% +$32.5M
LDOS icon
99
Leidos
LDOS
$16.4B
$40.2M 0.25%
681,995
+517,591
+315% +$28.8M
AMD icon
100
Advanced Micro Devices
AMD
$860B
$38.6M 0.24%
2,967,310
-85,424
-3% -$1.11M

Similar funds

Marshall Wace North America's Q3 2017 Portfolio in Review

As of Q3 2017, Marshall Wace North America held 1,739 positions worth $15.8B, up 16% from $13.7B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Marshall Wace North America deployed $1.31B of net new capital in Q3 2017, opening 469 new positions and adding to 384 existing holdings. Its largest new stake was Delta Air Lines: 1,523,510 shares worth $73.1M.

By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 21% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Terminix Global Holdings, Inc., an estimated $113M trimmed.

  • Marshall Wace North America's largest Q3 2017 buy was Delta Air Lines: 1,523,510 shares worth $73.1M.
  • Marshall Wace North America added most to Johnson & Johnson in Q3 2017, an estimated $260M increase.
  • Marshall Wace North America's biggest Q3 2017 reduction was Terminix Global Holdings, Inc., cutting an estimated $113M.
  • Marshall Wace North America fully exited Reynolds American Inc in Q3 2017, selling an estimated $130M.
  • Marshall Wace North America's ten largest holdings make up 14% of its $15.8B portfolio in Q3 2017.
  • Marshall Wace North America opened 469 new positions and closed 529 in Q3 2017.
  • Marshall Wace North America's portfolio value rose 16% quarter-over-quarter to $15.8B.

Based on Marshall Wace North America's 13F filing for Q3 2017, filed 13 Nov 2017.